AD Masterclass Virtual Series 1

Speciality: Dermatology

Description:

A warm welcome to all the medical professionals in this interesting session on AD Masterclass Virtual Series 1 - Newer advances in the management of Atopic dermatitis & role of PDE4 Inhibitor
The AD Masterclass Virtual Series 1 focused on the latest advancements in managing atopic dermatitis (AD), offering insights into evolving treatment strategies. Recent years have seen significant progress in understanding AD's underlying immune pathways, leading to the development of targeted therapies. Newer treatments, such as biologics and small molecule inhibitors, have transformed the way moderate to severe cases are managed, improving both symptom control and long-term outcomes for patients.
A key highlight of the series was the role of phosphodiesterase 4 (PDE4) inhibitors, like crisaborole, in AD management. PDE4 inhibitors work by reducing inflammation through the inhibition of pro-inflammatory cytokine production, providing relief from itching, redness, and other AD symptoms. These medications are particularly valuable for patients seeking non-steroidal options with a favorable safety profile, making them suitable for long-term use in mild to moderate cases. The virtual series underscored how PDE4 inhibitors are now a crucial part of the evolving AD treatment landscape.
Therefore, get an overall knowledge of AD masterclass virtual series 1 - newer advances in the management of atopic dermatitis & role of PDE4 inhibitor
 

See More Webinars @ Hidoc Webinars